....' The trick is not to suffer a debilatating loss of capital through the market hiccups, which is easier said than done.'...lol and aint that the fly in the ointment on anyones system :)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
